Renal effects of SB 7505: A double-blind study
- 1 February 1981
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 19 (3) , 177-180
- https://doi.org/10.1007/bf00561945
Abstract
Two groups of 20 patients with no evidence of cardiovascular, hepatic, renal or gastrointestinal failure were treated orally for five days with placebo or SB 7505 100 mg/day. No change was observed in heart rate or blood pressure. Urine output, the excretion of Na, K and Cl, and creatinine clearance were significantly increased.Keywords
This publication has 2 references indexed in Scilit: